This reactor, it is reported, can be continuously refueled without being shut down and operate stably for long periods. It offers high efficiency, large output, high specific activity, continuous production, and a stable supply of isotopes for mass production.
The inauguration of this new reactor comes after months of development and upgrade of the facility. It can now produce a variety of short-lived medical isotopes, including Strontium-89 (Sr-89) and Yttrium-90 (Y-90), on a large scale.